Johnson & Johnson (NYSE: JNJ) Q2 2021 earnings call dated Jul. 21, 2021 Corporate Participants: Christopher DelOrefice -- Vice President, Investor Relations Joseph J.
Johnson & Johnson
-(JNJ)
Get the latest Johnson & Johnson (JNJ) stock news, earnings analysis, earnings conference calls, earnings transcripts from AlphaStreet.
Johnson & Johnson beats in Q2; raises FY guidance
Johnson & Johnson (NYSE: JNJ) reported second-quarter 2021 financial results before the regular market hours on Wednesday. The pharmaceutical giant reported Q2
Earnings calendar for the week of July 19
Despite strong trading and encouraging news from the labor market, benchmark stock indexes pulled back after making modest gains early in the
Johnson & Johnson (JNJ) Q1 2021 Earnings Call
Johnson & Johnson (NYSE: JNJ) Q1 2021 earnings call dated Apr. 20, 2021 Corporate Participants: Christopher DelOrefice — Vice President of Investor Relations Joseph J. Wolk — Executive Vice
Johnson & Johnson (JNJ) Q1 2021 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q1 2021 earnings call dated Apr. 20, 2021 Corporate Participants: Christopher DelOrefice -- Vice President of Investor Relations Joseph
Johnson & Johnson (JNJ) reports Q1 2021 earnings
Johnson & Johnson (NYSE: JNJ) reported first-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue
Earnings calendar for the week of April 19
The market rally gathered pace this week amid impressive quarterly results, led by the banking sector, and positive economic data. Leading stock
What’s happening on the COVID-19 front? Here are a few updates.
Right about this time last year, the COVID-19 pandemic took over the world with full force as several countries went into complete
Where do these companies stand in the COVID-19 vaccine race?
After the struggle with the COVID-19 pandemic and its impacts clouding most of 2020, the rollout of vaccines against COVID-19 is the
Johnson & Johnson’s (JNJ) single-dose vaccine is effective but lags behind rivals
Johnson & Johnson (NYSE: JNJ) is the latest pharma company to provide results from the trial of its COVID-19 vaccine candidate. The company
Johnson & Johnson (JNJ) Q4 2020 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q4 2020 earnings call dated Jan. 26, 2021. Corporate Participants: Chris DelOrefice — Vice President, Investor Relations Alex Gorsky — Chairman
Johnson & Johnson (JNJ): Strength in ecommerce drives growth in Consumer Health
Shares of Johnson & Johnson (NYSE: JNJ) gained nearly 3% in morning trade on Tuesday after the company reported fourth quarter 2020
Johnson & Johnson (JNJ) beats market estimates in Q4
Johnson & Johnson (NYSE: JNJ) reported fourth-quarter 2020 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported fourth-quarter
Earnings calendar for the week of January 25
Leading stock indices continued the recent rally this week, with S&P 500 and Dow Jones Industrial Average setting new records helped mainly
Johnson & Johnson’s (JNJ) COVID-19 vaccine would have an edge over others without this glitch
Johnson & Johnson (NYSE: JNJ) saw its shares climb 2% on Thursday after the company reported positive results from the early-stage trials
Earnings calendar for the week of January 11
Stock markets responded positively to the latest developments in presidential election. On the heels of the Dow Jones Industrial Average achieving a
COVID vaccine: Single-dose regimen can give Johnson & Johnson (JNJ) an edge
Johnson & Johnson (NYSE: JNJ) has adopted a slow and steady approach in its COVID vaccine research, which is one of the
COVID-19 vaccine: Pfizer (PFE) and Moderna (MRNA) are ahead in the race, where are the others?
Pfizer Inc. (NYSE: PFE) and Moderna Inc. (NASDAQ: MRNA) have made significant progress in their efforts to develop a vaccine against the
Johnson & Johnson (JNJ) Q3 2020 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q3 2020 earnings call dated Oct. 13, 2020 Corporate Participants: Christopher DelOrefice -- Vice President of Investor Relations Joseph
Johnson & Johnson (JNJ) Q3 earnings: Infographic
Johnson & Johnson (NYSE: JNJ) reported third-quarter 2020 financial results before the opening bell on Tuesday. The pharmaceutical giant reported a 2%
Earnings reports to watch for the week of Oct. 12
Despite uncertainties, investors kept hopes high on a COVID-related economic stimulus this week. Riding on the positive sentiments from last week, major